Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse events Asymptomatic, reversible grade 3 liver enzyme elevations occurred in three ...
Highlighting Regulatory and Clinical Leadership in Regenerative Exosome TherapiesTORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback